Audrey Frist
Lab Manager
Last active: 3/18/2014


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Selective small molecule targeting β-catenin function discovered by in vivo chemical genetic screen. Hao J, Ao A, Zhou L, Murphy CK, Frist AY, Keel JJ, Thorne CA, Kim K, Lee E, Hong CC (2013) Cell Rep 4(5): 898-904
    › Primary publication · 24012757 (PubMed) · PMC3923627 (PubMed Central)
  2. Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe. Engers DW, Frist AY, Lindsley CW, Hong CC, Hopkins CR (2013) Bioorg Med Chem Lett 23(11): 3248-52
    › Primary publication · 23639540 (PubMed) · PMC3677712 (PubMed Central)
  3. Enteric nervous system specific deletion of Foxd3 disrupts glial cell differentiation and activates compensatory enteric progenitors. Mundell NA, Plank JL, LeGrone AW, Frist AY, Zhu L, Shin MK, Southard-Smith EM, Labosky PA (2012) Dev Biol 363(2): 373-87
    › Primary publication · 22266424 (PubMed) · PMC3288190 (PubMed Central)
  4. Loss of Foxd3 results in decreased β-cell proliferation and glucose intolerance during pregnancy. Plank JL, Frist AY, LeGrone AW, Magnuson MA, Labosky PA (2011) Endocrinology 152(12): 4589-600
    › Primary publication · 21952247 (PubMed) · PMC3230055 (PubMed Central)
  5. Influence and timing of arrival of murine neural crest on pancreatic beta cell development and maturation. Plank JL, Mundell NA, Frist AY, LeGrone AW, Kim T, Musser MA, Walter TJ, Labosky PA (2011) Dev Biol 349(2): 321-30
    › Primary publication · 21081123 (PubMed) · PMC3019241 (PubMed Central)
  6. Requirement for Foxd3 in the maintenance of neural crest progenitors. Teng L, Mundell NA, Frist AY, Wang Q, Labosky PA (2008) Development 135(9): 1615-24
    › Primary publication · 18367558 (PubMed) · PMC2562748 (PubMed Central)
  7. Effects of adenovirus-mediated expression of p27Kip1, p21Waf1 and p16INK4A in cell lines derived from t(2;5) anaplastic large cell lymphoma and Hodgkin's disease. Turturro F, Arnold MD, Frist AY, Seth P (2002) Leuk Lymphoma 43(6): 1323-8
    › Primary publication · 12153002 (PubMed)
  8. Model of inhibition of the NPM-ALK kinase activity by herbimycin A. Turturro F, Arnold MD, Frist AY, Pulford K (2002) Clin Cancer Res 8(1): 240-5
    › Primary publication · 11801565 (PubMed)
  9. Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27(Kip1). Turturro F, Frist AY, Arnold MD, Seth P, Pulford K (2001) Oncogene 20(33): 4466-75
    › Primary publication · 11494142 (PubMed)
  10. Comparison of the effects of recombinant adenovirus-mediated expression of wild-type p53 and p27Kip1 on cell cycle and apoptosis in SUDHL-1 cells derived from anaplastic large cell lymphoma. Turturro F, Frist AY, Arnold MD, Pal A, Cook GA, Seth P (2001) Leukemia 15(8): 1225-31
    › Primary publication · 11480564 (PubMed)
  11. Polymerization of fibrinogen in murine bleomycin-induced lung injury. Olman MA, Simmons WL, Pollman DJ, Loftis AY, Bini A, Miller EJ, Fuller GM, Rivera KE (1996) Am J Physiol 271(4 Pt 1): L519-26
    › Primary publication · 8897898 (PubMed)